The first issue of our collaborative newsletter was succesfully launched during the summer, featuring contributions from all of you. Thank you for your contributions and your willingness to participate.
It was a good start, but we believe can give
It was a good start, but we believe can give an extra push to building our subscriber base.
#+END_VERSE
- TODO PENSAR sobre taller de [[GEPI]] sobre efectos secundarios del [[benznidazol]] que se hará en algún momento de [[2025]]